International Journal of Cancer Management

Published by: Kowsar

Three-Month and Three-Year Survival Rates and Complications of Transthoracic Surgery in Patients with Esophageal Cancer at Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences

Mojtaba Javaherzadeh 1 , Babak Sabet 1 , * , Ali Solouki 2 , Ahmad Javanmard 3 and Ali Shekarchizadeh 4
Authors Information
1 Associate Professor, Department of Surgery, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Surgeon, Department of Surgery, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Researcher , Department of Nutrition, Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Researcher, Poursina Hakim Gastrointestinal (GI) Research Center, Poursina Hakim Research Institution, Isfahan, Iran
Article information
  • Iranian Journal of Cancer Prevention: December 2016, 9 (6); e6456
  • Published Online: December 10, 2016
  • Article Type: Research Article
  • Received: April 18, 2016
  • Revised: September 11, 2016
  • Accepted: December 3, 2016
  • DOI: 10.17795/ijcp-6456

To Cite: Javaherzadeh M, Sabet B, Solouki A, Javanmard A, Shekarchizadeh A. Three-Month and Three-Year Survival Rates and Complications of Transthoracic Surgery in Patients with Esophageal Cancer at Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Int J Cancer Manag. 2016 ; 9(6):e6456. doi: 10.17795/ijcp-6456.

Abstract
Copyright © 2016, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Barreto JC, Posner MC. Transhiatal versus transthoracic esophagectomy for esophageal cancer. World J Gastroenterol. 2010; 16(30): 3804-10[DOI][PubMed]
  • 2. Zeng J, Liu JS. Quality of life after three kinds of esophagectomy for cancer. World J Gastroenterol. 2012; 18(36): 5106-13[DOI][PubMed]
  • 3. Homesh NA, Alsabahi AA, Al-Agmar MH, Alwashaly AA, Valenzuela RE, Alhadid MA, et al. Transhiatal versus transthoracic resection for oesophageal carcinoma in Yemen. Singapore Med J. 2006; 47(1): 54-9[PubMed]
  • 4. Gockel I, Heckhoff S, Messow CM, Kneist W, Junginger T. Transhiatal and transthoracic resection in adenocarcinoma of the esophagus: does the operative approach have an influence on the long-term prognosis? World J Surg Oncol. 2005; 3: 40[DOI][PubMed]
  • 5. Gluch L, Smith RC, Bambach CP, Brown AR. Comparison of outcomes following transhiatal or Ivor Lewis esophagectomy for esophageal carcinoma. World J Surg. 1999; 23(3): 271-5[DOI][PubMed]
  • 6. Walther B, Johansson J, Johnsson F, Von Holstein CS, Zilling T. Cervical or thoracic anastomosis after esophageal resection and gastric tube reconstruction: a prospective randomized trial comparing sutured neck anastomosis with stapled intrathoracic anastomosis. Ann Surg. 2003; 238(6): 803-12[DOI][PubMed]
  • 7. de Boer AG, van Lanschot JJ, van Sandick JW, Hulscher JB, Stalmeier PF, de Haes JC, et al. Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol. 2004; 22(20): 4202-8[DOI][PubMed]
  • 8. Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, van Dekken H, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007; 246(6): 992-1000[DOI][PubMed]
  • 9. Anvari K, Aledavood SA, Toussi MS, Forghani MN, Mohtashami S, Rajabi MT, et al. A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma. J Res Med Sci. 2015; 20(8): 751-6[DOI][PubMed]
  • 10. Ganesamoni S, Krishnamurthy A. Three-field transthoracic versus transhiatal esophagectomy in the management of carcinoma esophagus-a single--center experience with a review of literature. J Gastrointest Cancer. 2014; 45(1): 66-73[DOI][PubMed]
  • 11. Wolf DC. Clinical Methods: The History, Physical, and Laboratory Examinations Dysphagia. 1990;
  • 12. Noshiro H, Yoda Y, Hiraki M, Kono H, Miyake S, Uchiyama A, et al. Survival outcomes of 220 consecutive patients with three-staged thoracoscopic esophagectomy. Dis Esophagus. 2016; 29(8): 1090-9[DOI][PubMed]
  • 13. Rindani R, Martin CJ, Cox MR. Transhiatal versus Ivor-Lewis oesophagectomy: is there a difference? Aust N Z J Surg. 1999; 69(3): 187-94[DOI][PubMed]
  • 14. Niwa Y, Koike M, Hattori M, Iwata N, Takami H, Hayashi M, et al. Short-term outcomes after conventional transthoracic esophagectomy. Nagoya J Med Sci. 2016; 78(1): 69-78[PubMed]
  • 15. Igaki H, Tachimori Y, Kato H. Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg. 2004; 239(4): 483-90[DOI][PubMed]
  • 16. Makela J, Laitinen S, Kairaluoma MI. A comparison of transthoracic and transhiatal resection for thoracic oesophageal cancer. Observations of 30 years. Ann Chir Gynaecol. 1991; 80(4): 340-5[PubMed]
  • 17. D'Journo XB, Berbis J, Jougon J, Brichon PY, Mouroux J, Tiffet O, et al. External validation of a risk score in the prediction of the mortality after esophagectomy for cancer. Dis Esophagus. 2016; [DOI][PubMed]
  • 18. Chang AC, Ji H, Birkmeyer NJ, Orringer MB, Birkmeyer JD. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg. 2008; 85(2): 424-9[DOI][PubMed]
  • 19. Mamidanna R, Ni Z, Anderson O, Spiegelhalter SD, Bottle A, Aylin P, et al. Surgeon Volume and Cancer Esophagectomy, Gastrectomy, and Pancreatectomy: A Population-based Study in England. Ann Surg. 2016; 263(4): 727-32[DOI][PubMed]
  • 20. Ma L, Li J, Shao L, Lin D, Xiang J. Prolonged postoperative length of stay is associated with poor overall survival after an esophagectomy for esophageal cancer. J Thorac Dis. 2015; 7(11): 2018-23[DOI][PubMed]
  • 21. Sugimura K, Motoori M, Yano M, Ishihara R, Hanaoka N, Miyoshi N. Endoscopic steroid injection reduced frequency of repeat dilation in patients with anastomotic stenosis after esophagectomy. Esophagus. 2016; 13(1): 62-7[DOI]
  • 22. Messager M, Warlaumont M, Renaud F, Marin H, Branche J, Piessen G. Recent improvements in the management of esophageal anastomotic leak after surgery for cancer. Eur J Surg Oncol. 2016; [DOI]
  • 23. Goan YG, Chang HC, Hsu HK, Chou YP. An audit of surgical outcomes of esophageal squamous cell carcinoma. Eur J Cardiothorac Surg. 2007; 31(3): 536-44[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments